890 related articles for article (PubMed ID: 16238897)
21. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
[TBL] [Abstract][Full Text] [Related]
22. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.
Wald A; Zeh J; Selke S; Warren T; Ryncarz AJ; Ashley R; Krieger JN; Corey L
N Engl J Med; 2000 Mar; 342(12):844-50. PubMed ID: 10727588
[TBL] [Abstract][Full Text] [Related]
23. An update on short-course episodic and prevention therapies for herpes genitalis.
Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
[TBL] [Abstract][Full Text] [Related]
24. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
[TBL] [Abstract][Full Text] [Related]
25. [Natural history of HSV1 and HSV2 infection. Asymptomatic viral excretion. Mother-infant transmission. Indirect transmission].
Morand P
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):577-85. PubMed ID: 12122327
[TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
28. Acyclovir suppression to prevent recurrent genital herpes at delivery.
Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
Infect Dis Obstet Gynecol; 2002; 10(2):71-7. PubMed ID: 12530483
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of genital herpes - recent advances.
Halioua B; Malkin JE
Eur J Dermatol; 1999; 9(3):177-84. PubMed ID: 10210781
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of genital herpes.
Kinghorn GR
J Int Med Res; 1994; 22 Suppl 1():14A-23A. PubMed ID: 8063020
[TBL] [Abstract][Full Text] [Related]
31. Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?
Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
Antiviral Res; 2004 Aug; 63 Suppl 1():S3-9. PubMed ID: 15450380
[TBL] [Abstract][Full Text] [Related]
32. Genital shedding of herpes simplex virus among men.
Wald A; Zeh J; Selke S; Warren T; Ashley R; Corey L
J Infect Dis; 2002 Oct; 186 Suppl 1():S34-9. PubMed ID: 12353185
[TBL] [Abstract][Full Text] [Related]
33. [Mother-infant and indirect transmission of HSV infection: treatment and prevention].
Henrot A
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):533-49. PubMed ID: 12122323
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.
Langenberg AG; Corey L; Ashley RL; Leong WP; Straus SE
N Engl J Med; 1999 Nov; 341(19):1432-8. PubMed ID: 10547406
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of safety and efficacy of prolonged suppressive therapy of genital herpes with valacyclovir.
Durglishvili N; Shishniashvili D; Kvirkvelia V
Georgian Med News; 2009; (172-173):47-9. PubMed ID: 19644189
[TBL] [Abstract][Full Text] [Related]
36. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection.
Hollier LM; Wendel GD
Cochrane Database Syst Rev; 2008 Jan; (1):CD004946. PubMed ID: 18254066
[TBL] [Abstract][Full Text] [Related]
37. Herpes simplex virus type 2 transmission: risk factors and virus shedding.
Wald A
Herpes; 2004 Aug; 11 Suppl 3():130A-137A. PubMed ID: 15319082
[TBL] [Abstract][Full Text] [Related]
38. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.
Krone MR; Wald A; Tabet SR; Paradise M; Corey L; Celum CL
Clin Infect Dis; 2000 Feb; 30(2):261-7. PubMed ID: 10671325
[TBL] [Abstract][Full Text] [Related]
39. Valacyclovir. New indication: for genital herpes, simpler administration.
Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269
[TBL] [Abstract][Full Text] [Related]
40. Condom use and the prevention of genital herpes acquisition.
Casper C; Wald A
Herpes; 2002 Apr; 9(1):10-4. PubMed ID: 11916494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
